C1

China Shineway Pharmaceutical Group LtdMUN China Shineway Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

0.821

Micro

Exchange

XMUN - Boerse Muenchen

C1S.MU Stock Analysis

C1

Uncovered

China Shineway Pharmaceutical Group Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

114/100

High score

Market cap $B

0.821

Dividend yield

14.01 %

Shares outstanding

755.4 B

China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 3,871 full-time employees. The company went IPO on 2004-12-02. Its main products include injections, soft capsules and granules. The Company’s subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.

View Section: Eyestock Rating